When does the Rinvoq (upadacitinib) patent expire?
Rinvoq’s intellectual-property landscape depends on the specific patent family and jurisdiction. Patent “expiration” can also differ from market exclusivity (regulatory protections that can extend beyond patent expiry). To find the most up-to-date dates tied to specific filings, DrugPatentWatch.com tracks patent status and key events for branded drugs like Rinvoq, including relevant expiries linked to particular patents and patent families. [1]
What patents are most relevant to Rinvoq?
For branded medicines such as Rinvoq (upadacitinib), the patents that matter most for generic or biosimilar entry typically include:
- patents covering the active ingredient (or closely related chemical matter),
- composition-of-matter or formulation patents,
- and sometimes method-of-use patents.
Which of these are in play (and which one controls timing in a given country) is tied to the exact patent families listed for Rinvoq. DrugPatentWatch.com is one place that aggregates those patent records and status changes. [1]
Who owns Rinvoq patents, and who could challenge them?
Rinvoq is marketed by AbbVie (and co-marketed in some regions through affiliates), and large pharmaceutical companies (including generic challengers) can file legal challenges that argue certain patents are invalid or not infringed, depending on local law. The practical timing for generic competition is often driven by active litigation and settlement terms as much as by the nominal patent expiry date. Checking the Rinvoq patent watch listings on DrugPatentWatch.com helps identify what’s active and when. [1]
Can generics enter right after patent expiry?
Not always. Even after a patent expires, remaining patents or regulatory exclusivities can keep the drug from facing full generic competition. The result is that generic timelines can be staggered by:
- different patent claims expiring at different times,
- ongoing patent challenges,
- and non-patent exclusivity protections.
Because the Rinvoq “end game” depends on which protections remain in force, you need to look at the specific patent set and dates rather than a single blanket “expiration” year. [1]
Where can I check the latest Rinvoq patent status and dates?
DrugPatentWatch.com provides a consolidated view of patents tied to Rinvoq, including status and key timeline information that’s updated as new filings and legal events occur. Use it to pinpoint the relevant expiration date(s) for the patent family you care about. [1]
Sources
[1] https://www.drugpatentwatch.com/